qiagen-and-calmette-hospital-in-cambodia-will-develop-national-standards-on-screening-for-human-papillomavirus-hpv-the-primary-cause-of-cervical-cancer

Qiagen develops cancer screening standards in Cambodia

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Qiagen is partnering with Calmette Hospital in Cambodia to help develop national standards on screening for human papillomavirus (HPV), the primary cause... Read more

cmc-biologics-and-ruiyi-to-develop-cell-line-for-novel-anti-il-6-monoclonal-antibody-ryi-008

CMC, RuiYi develop monoclonal antibodies cell line

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based contract biopharmaceutical manufacturing CMC Biologics has collaborated with China-focused RuiYi to develop a cell line for RYI-008, a novel... Read more

twi-guanfacine-hydrochloride-abbreviated-new-drug-application-anda-gets-fda-approval

TWi Pharma gets FDA nod for ADHD drug

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (ANDA) for Guanfacine Hydrochloride extended... Read more

singapore-is-ranked-3rd-in-the-2012-global-innovation-index-co-published-by-insead-and-the-world-intellectual-property-organization-wipo-behind-sweden-and-switzerland

Singapore is Asia's innovation capital

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Singapore has received recognition in five global tracking studies in the area of innovation and research and development (R&D). After 20 years of long... Read more

ranbaxy-has-been-hit-hard-by-the-gavel

Ranbaxy pleads guilty, will pay $500 mn to the US

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: Ranbaxy Laboratories has reached a final settlement agreement regarding a previously disclosed investigation by the US Department of Justice (DOJ) of... Read more

frost-sullivan-partner-ms-reenita-das-says-that-personalization-communication-decentralization-and-collaboration-are-the-new-mantra-in-healthcare

F&S: Personalization is the new mantra in healthcare

  • Japan
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Frost & Sullivan partner Ms Reenita Das during her keynote presentation at the 12th International BIOtech Exhibition and Conference in Tokyo, revealed... Read more

agilent-technologies-launches-advancebio-peptide-mapping-biohplc-and-zorbax-rrhd-300-hilic-columns

Agilent AdvanceBio peptide mapper hits market

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Agilent Technologies has launched AdvanceBio Peptide Mapping BioHPLC and Zorbax RRHD 300-HILIC columns, designed to deliver exceptional performance for... Read more

linden-bioscience-submits-marketing-approval-application-for-its-bsd-2000-hyperthermia-system-to-the-taiwan-fda

BSD seeks Taiwan FDA nod for hyperthermia system

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Medical system provider, BSD Medical's Taiwan distributor Linden Bioscience has submitted its BSD-2000 marketing approval application for the BSD-2000... Read more

nymalize-nimodipine-was-previously-granted-orphan-designation-which-provides-seven-years-of-market-exclusivity

Arbor gets FDA approval for its first NDA

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US Food and Drug Administration (FDA) has approved Arbor Pharmaceutical's New Drug Application (NDA) for Nymalize (nimodipine) oral solution. Nymalize... Read more

home-care-devices-market-to-reach-usd1

Home care devices market to reach $1.21bn in 2016

  • Malaysia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: An analysis conducted by Frost & Sullivan regarding the Asia Pacific Home Care Devices Market, has revealed that the market earned approximately $967... Read more

scale-up-systems-and-scienview-will-provide-dynochem-software-to-the-chinese-pharmaceutical-industry

DynoChem bio-software makes way into China

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Scale-up Systems, a leading provider of process development software to the pharmaceutical industry, entered into a multi-year agreement with ScienView,... Read more

farewell-ms-anna-protopapas-executive-vp-of-bd-takeda-will-replace-millennium-pharma-s-outgoing-ceo-ms-deborah-dunsire

CEO of Takeda's Millennium Pharma quits abruptly

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Ms Deborah Dunsire, CEO, Millennium Pharmaceuticals, is leaving the company in an abrupt departure. Ms Dunsire fueled the emergence of Millennium Pharma... Read more

australia-to-host-11th-annual-world-congress-of-the-society-for-brain-mapping-and-therapeutics-sbmt-during-march-2014

Aus to host first world brain mapping congress

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AusBiotech is holding 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT) in Sydney, Australia, for the first time ever.... Read more

scientists-discover-genetic-mutation-that-causes-sturge-weber-syndrome-sws-and-port-wine-stain-birthmarks-image-source-www

Sturge-Weber Syndrome's mutation discovered

Singapore: Researchers from Kennedy Krieger Institute, US, have found a genetic mutation that occurs before birth and can lead to Sturge-Weber syndrome (SWS) and... Read more

scinopharm-taiwan-and-coland-to-develop-generic-oncological-drugs-for-china

ScinoPharm, Coland develop cancer generics in China

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to develop a series of generic oncological drugs... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X